cobaltous chloride has been researched along with glyburide in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bosco, D; Chanson, M; Giordano, E; Meda, P; Soria, B | 1 |
| Arayne, MS; Farooq, A; Sultana, N; Zaman, MK | 1 |
| Fei, F; Li, L; Luo, L; Qu, Y; Rong, Z | 1 |
3 other study(ies) available for cobaltous chloride and glyburide
| Article | Year |
|---|---|
Ion channels of glucose-responsive and -unresponsive beta-cells.
Topics: Animals; Cobalt; Electrophysiology; Glucose; Glyburide; Hemolytic Plaque Technique; In Vitro Techniques; Ion Channels; Islets of Langerhans; Male; Membrane Potentials; Potassium Channels; Potassium Chloride; Rats; Rats, Inbred Strains; Sodium Channels; Tolbutamide | 1991 |
Synthesis and characterization of glibenclamide complexes of magnesium, chromium, cobalt, nickel, zinc and cadmium salts.
Topics: Cadmium Chloride; Chlorides; Chromium Compounds; Cobalt; Glyburide; Hypoglycemic Agents; Magnesium Chloride; Magnetic Resonance Spectroscopy; Metals; Nickel; Spectrophotometry, Atomic; Spectrophotometry, Infrared; Transition Temperature; Zinc Compounds | 2006 |
Combined treatment of glibenclamide and CoCl2 decreases MMP9 expression and inhibits growth in highly metastatic breast cancer.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cobalt; Female; Gene Expression Regulation, Neoplastic; Glyburide; Humans; Matrix Metalloproteinase 9; Mice; Neoplasm Metastasis; Proliferating Cell Nuclear Antigen; RNA, Messenger; Tumor Burden | 2013 |